Park Hee Jin, Kim Soo Hyun, Jung Yong Wook, Shim Sung Shin, Kim Ji Yeon, Cho Yeon Kyung, Farina Antonio, Zanello Margherita, Lee Kyoung Jin, Cha Dong Hyun
Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Republic of Korea.
BMC Pregnancy Childbirth. 2014 Jan 20;14:35. doi: 10.1186/1471-2393-14-35.
Our primary objective was to establish a cutoff value for the soluble fms-like tyrosine kinase 1(sFlt-1)/placental growth factor (PlGF) ratio measured using the Elecsys assay to predict late-onset preeclampsia in low-risk pregnancies. Our secondary objective was to evaluate the ability of combination models using Elecsys data, second trimester uterine artery (UtA) Doppler ultrasonography measurements, and the serum fetoplacental protein levels used for Down's syndrome screening, to predict preeclampsia.
This prospective cohort study included 262 pregnant women with a low risk of preeclampsia. Plasma levels of pregnancy-associated plasma protein-A (PAPP-A) and serum levels of alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin, and inhibin-A were measured, and sFlt-1/PlGF ratios were calculated. All women underwent UtA Doppler ultrasonography at 20 to 24 weeks of gestation.
Eight of the 262 women (3.0%) developed late-onset preeclampsia. Receiver operating characteristic curve analysis showed that the third trimester sFlt-1/PlGF ratio yielded the best detection rate (DR) for preeclampsia at a fixed false-positive rate (FPR) of 10%, followed by the second trimester sFlt-1/PlGF ratio, sFlt-1 level, and PlGF level. Binary logistic regression analysis was used to determine the five best combination models for early detection of late-onset preeclampsia. The combination of the PAPP-A level and the second trimester sFlt-1/PlGF ratio yielded a DR of 87.5% at a fixed FPR of 5%, the combination of second and third trimester sFlt-1/PlGF ratios yielded a DR of 87.5% at a fixed FPR of 10%, the combination of body mass index and the second trimester sFlt-1 level yielded a DR of 87.5% at a fixed FPR of 10%, the combination of the PAPP-A and inhibin-A levels yielded a DR of 50% at a fixed FPR of 10%, and the combination of the PAPP-A level and the third trimester sFlt-1/PlGF ratio yielded a DR of 62.5% at a fixed FPR of 10%.
The combination of the PAPP-A level and the second trimester sFlt-1/PlGF ratio, and the combination of the second trimester sFlt-1 level with body mass index, were better predictors of late-onset preeclampsia than any individual marker.
我们的主要目标是确定使用电化学发光免疫分析法(Elecsys)测量的可溶性fms样酪氨酸激酶1(sFlt-1)/胎盘生长因子(PlGF)比值的临界值,以预测低风险妊娠中的晚发型子痫前期。我们的次要目标是评估结合Elecsys数据、孕中期子宫动脉(UtA)多普勒超声测量结果以及用于唐氏综合征筛查的血清胎儿胎盘蛋白水平的联合模型预测子痫前期的能力。
这项前瞻性队列研究纳入了262名单纯子痫前期低风险孕妇。检测血浆妊娠相关血浆蛋白A(PAPP-A)水平以及血清甲胎蛋白、游离雌三醇、人绒毛膜促性腺激素和抑制素A水平,并计算sFlt-1/PlGF比值。所有女性在妊娠20至24周时接受UtA多普勒超声检查。
262名女性中有8名(3.0%)发生晚发型子痫前期。受试者工作特征曲线分析表明,在固定假阳性率(FPR)为10%时,孕晚期sFlt-1/PlGF比值对子痫前期的检测率(DR)最高,其次是孕中期sFlt-1/PlGF比值、sFlt-1水平和PlGF水平。采用二元逻辑回归分析确定早期检测晚发型子痫前期的五个最佳联合模型。在固定FPR为5%时PAPP-A水平与孕中期sFlt-1/PlGF比值的联合检测率为87.5%,在固定FPR为10%时孕中期与孕晚期sFlt-1/PlGF比值的联合检测率为87.5%,在固定FPR为10%时体重指数与孕中期sFlt-1水平的联合检测率为87.5%,在固定FPR为10%时PAPP-A与抑制素A水平的联合检测率为50%,在固定FPR为10%时PAPP-A水平与孕晚期sFlt-1/PlGF比值的联合检测率为62.5%。
与任何单一标志物相比,PAPP-A水平与孕中期sFlt-1/PlGF比值的联合以及孕中期sFlt-1水平与体重指数的联合是晚发型子痫前期更好的预测指标。